Source: Annual Congress 2005 - Outcome of pulmonary rehabilitation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. Archinucci, M. Biagini, R. Scala, P. Baldi, M. Nucci, M. Naldi (Arezzo, Italy). Rehabilitation programs in patients in different severity stage of COPD (GOLD II-to-IV): analysis of the results. Eur Respir J 2005; 26: Suppl. 49, 538

Member's Comments

No comment yet.

Related content which might interest you: Validation of non-spirometric predictors of COPD to the GOLD stage classification Source: Eur Respir J 2002; 20: Suppl. 38, 123s Year: 2002 Characterization of patients with COPD GOLD stage I and II referred for pulmonary rehabilitation Source: International Congress 2015 – Latest insights into chronic care Year: 2015 Distribution of COPD patients in the GOLD assessment framework by exacerbations Source: Annual Congress 2012 - COPD epidemiology Year: 2012 Impact of comorbidities on survival of patients with COPD according to GOLD stages Source: Annual Congress 2011 - COPD: burden of disease, imaging and management Year: 2011 Distribution and significance of GOLD 2011 disease severity classification in patients with COPD in China: A national cross-sectional survey Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 Results of a pulmonary rehabilitation program (PRP) in COPD patients: Differences in outcomes according to currently 2011 GOLD groups Source: International Congress 2014 – Best posters in pulmonary rehabilitation 2 Year: 2014 The effect of outpatient pulmonary rehabilitation on COPD assessment test (CAT) and GOLD classification – A retrospective data analysis Source: International Congress 2015 – Latest insights into pulmonary rehabilitation Year: 2015 COPD severity analysis according to current evaluation criteria – National survey Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 GOLD BCD or 234 classifications: Which one better reflects COPD patients' functionality? Source: International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD Year: 2014 GOLD assessment of COPD patients: Impact of symptoms assessment choice Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD Year: 2012 High risk COPD patients cost less if treated according to GOLD 2011 recommendations Source: Annual Congress 2013 –COPD diagnosis Year: 2013 The distribution of COPD in general practice using three different GOLD classification Source: International Congress 2018 – COPD around the world Year: 2018 Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2015 and GOLD 2019 staging systems: a pooled analysis of individual patient data Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020 Does the effectiveness of pulmonary rehabilitation vary in patients with different baseline severity of symptoms classified by MRC grade? Source: Annual Congress 2013 –The latest insights in pulmonary rehabilitation (part 2) Year: 2013 Evaluation of the GOLD 2011 severity criteria across the COPD spectrum Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Predictors of the level of daily activities for different GOLD COPD stages Source: Eur Respir J 2007; 30: Suppl. 51, 127s Year: 2007 An acute bronchitis questionnaire (AECB-SS) discriminates between GOLD categories for COPD severity in patients screened for the MOSAIC study Source: Eur Respir J 2004; 24: Suppl. 48, 239s Year: 2004 Survival in three years of COPD patients according to GOLD 2003 and GOLD 2014 Source: International Congress 2015 – Latest insights into the management of chronic respiratory diseases Year: 2015 Comparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classification Source: Eur Respir J 2013; 42: 647-654 Year: 2013 Heterogeneity of group D in the new GOLD classification of COPD Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016